Work

Phase III clinical trials in chemotherapy-naive patients with advanced NSCLC assessing the combination of atezolizumab and chemotherapy

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw383.94

Authors: M. Reck, V.A. Papadimitrakopoulou, F. Cappuzzo, R. Jotte, T.S.K. Mok, A. Sandler, D. Waterkamp, S. Coleman, T. Asakawa, M. Socinski

Institutions: LungenClinic Grosshansdorf, The University of Texas MD Anderson Cancer Center, Ospedale di Livorno, Rocky Mountain Cancer Centers, Chinese University of Hong Kong, Genentech, University of Pittsburgh, University of Pittsburgh Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2588169328

FWCI: 0.898

Cites:

Cited by: 6

Related to: 10